Advertisement
ResearchIn-Press PreviewHepatologyImmunologyOncology
Open Access |
10.1172/JCI200415
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Wang, J. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Wang, J. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Pan, Y. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by He, M. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Zheng, Z. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Zou, H. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Wu, T. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Zhang, Y. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Hu, Z. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Fu, Y. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Peng, W. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Yang, Z. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Xu, L. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Zhang, Y. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Chen, M. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Hu, D. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Chen, J. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Zhao, M. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Chen, D. in: PubMed | Google Scholar
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
Find articles by Zhou, Z. in: PubMed | Google Scholar
Published April 2, 2026 - More info
Immunotherapies achieve durable responses in several cancers but show limited efficacy in refractory hepatocellular carcinoma (HCC). The mechanisms by which hepatoma cells evade immune recognition and limit immune checkpoint blockade (ICB) efficacy are incompletely defined. Here, we identified tumor-intrinsic tescalcin (TESC) as a previously unrecognized phagocytic checkpoint that contributes to immune evasion and ICB resistance in HCC. Mechanistically, H3K4 methylation drove TESC expression in hepatoma cells, facilitating cytosolic Ca²⁺ buffering and attenuating endoplasmic reticulum (ER) stress-induced calreticulin (CALR) plasma membrane exposure, an essential “eat-me” signal. Consequently, this process abrogates membrane CALR-directed phagocytosis by antigen-presenting cells (APCs), including macrophages and dendritic cells, thereby impairing antigen presentation and subsequent T-cell activation. Clinically, elevated H3K4me3-TESC signaling was a promising prognostic biomarker for poor ICB response of HCC. Importantly, in vivo disruption of this axis restored APC phagocytic function and enhanced the antitumor effects of ICB therapy. Thus, targeting TESC-driven immune escape and its underlying epigenetic regulation may restore APC function and offer a precise therapeutic strategy to enhance immunotherapy efficacy in HCC.